Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07408167

AI Models in Clinical Pathology Diagnosis: A Multicenter RCT

Performance of AI Models in the Clinical Pathology Diagnostic Workflow: A Multicenter, Prospective, Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,060 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

The investigators plan to conduct a multicenter, prospective, randomized controlled trial to systematically evaluate the incremental value of pathology-based artificial intelligence (AI) models in a pan-disease diagnostic workflow. The study will primarily compare interpretation using an AI-assisted platform with conventional independent slide reading in terms of diagnostic accuracy (e.g., AUC), reading efficiency (e.g., diagnostic time), diagnostic report quality, diagnostic confidence (Likert scale), and pathologists' satisfaction with the AI model. Investigators will also assess superiority among less experienced (junior) pathologists and non-inferiority among more experienced (senior) pathologists. Successful completion of this project will provide high-level prospective evidence to support standardized deployment, quality control, and broader implementation of pathology AI in clinical practice. This trial may also evaluate the potential benefits and risks of using AI tools in medical research.

Detailed description

In this study, investigators plan to enroll 60 pathologists with varying levels of experience and 2,000 patients requiring pathological diagnosis, with whole-slide images (WSIs) collected.

Conditions

Interventions

TypeNameDescription
OTHERAI modelDoctors in this group are required to use the AI model to assist their diagnoses. The AI pathology model will provide a predicted result for each case.
OTHERControlPathologists will independently diagnose each case based on their own clinical experience, and will record both their time to diagnosis and their diagnostic confidence.

Timeline

Start date
2026-03-01
Primary completion
2028-12-31
Completion
2029-12-31
First posted
2026-02-13
Last updated
2026-02-13

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07408167. Inclusion in this directory is not an endorsement.